Khosla Ventures
Listed as “Synchron”
- First observed:
- 31 Oct 2026
- Investment announced:
- Date not recorded
Synchron
Synchron builds implantable brain-computer interfaces.
- Tracked VC backers
- 1
RiseFinder summary
Synchron builds implantable brain-computer interfaces. Its Stentrode device is implanted through the jugular vein and is being assessed in clinical trials for people living with paralysis. The device is investigational and limited to investigational use under US law.
- Company website ↗ · Checked
Tracking coverage and points
Tracking coverage
Some public sources are being tracked. Coverage varies by milestone.
- Momentum +1 · Tracking
- Comparable public measurements available. Points depend on your pick date.Last comparable reading:
- Fundraising +2 · Awaiting data
- No verified dated source evidence recorded.
- New VC +3 · Awaiting data
- No verified dated source evidence recorded.
- Completed exit +10 · Awaiting data
- Exit news coverage has not started.
Coverage describes public evidence. Points require a qualifying milestone after your pick.
Publicly documented VC backing
These sources establish that the firm lists the company. The observation date records when RiseFinder captured the relationship; it does not establish when the investment happened.
Dated public activity
No dated funding or investment events are recorded yet. Initial portfolio listings establish the starting baseline and earn no points.